Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Size: px
Start display at page:

Download "Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology"

Transcription

1 Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

2 Why do we need to know ovarian response? Anna Sarah Just do IVF and see response Kelsey and Wallace PLOS One 2010.

3 Mild stimulation: one size fits all or does it? Lower live birth rates Mild stimulation OHSS risk still exists Fewer embryos FSH Level Programming of the cycle Follicle size (mm) Individualised FSH-dosing algorithms not available Mild ovarian response Macklon, et al. Endocrine Reviews Fauser, et al. Hum Reprod

4 So what options do we have? Paracrine Control Environmental Factors Small Antral 2-5 mm Endocrine Control FSH and LH Dependent Dominant 10 mm Ovulatory 20 mm Atresia Atresia Atresia Atresia Atresia Recruitment Growth Menstrual cycle >120 days 85 days 14 days True ovarian reserve Functional reserve

5 Can we get a handle on number of small antral follicles? Normal AFC Low AFC Courtesy of N Raine Fenning

6 Can we get a handle on number of small antral follicles? AFC can be measured anywhere in the cycle Jayaprakasan, et al. HR 2008, UOG 2009.

7 Can we get a handle on number of small antral follicles? AFC can be measured anywhere in the cycle Improved accuracy with 3D and automated software 2D 3D 3D automated Jayaprakasan, et al. HR 2008, UOG 2009.

8 Can we get a handle on number of small antral follicles? AFC can be measured anywhere in the cycle Improved accuracy with 3D and automated software Good association with oocyte yield r = 0.66 with 2D Jayaprakasan, et al. HR 2008, UOG 2009.

9 Can we get a handle on number of small antral follicles? AFC can be measured anywhere in the cycle Improved accuracy with 3D and automated software Good association with oocyte yield r = 0.78 with 3D inversion Jayaprakasan, et al. HR 2008, UOG 2009.

10 Can we get a handle on number of small antral follicles? AFC can be measured anywhere in the cycle Improved accuracy with 3D and automated software Good association with oocyte yield Good prediction of poor response Jayaprakasan, et al. HR 2008, UOG 2009.

11 Can we get a handle on number of small antral follicles? AFC can be measured anywhere in the cycle Improved accuracy with 3D and automated software Good association with oocyte yield Good prediction of poor response Good prediction of excessive response Broer, et al. HRU 2011.

12 Can we get a handle on number of small antral follicles? AFC can be measured anywhere in the cycle Improved accuracy with 3D and automated software Good association with oocyte yield Good prediction of poor response Good prediction of excessive response FSH dose nomogram Broer, et al. HRU 2011.

13 Primary alternative are endocrine markers AMH in pre-antral and early antral follicles Image courtesy of Hamish Fraser, MRC.

14 The new AMH Gen II assay DSL antibody Immunotech standards Values ~40% higher Wallace, Faye, Fleming and Nelson Annals of Clin Biochem 2011 (in press).

15 AMH is stable within and across menstrual cycles Tsepelidis. Hum Reprod van Disseldorp, et al. Hum Reprod

16 AMH menstrual cycle stability is dependent on age pmol/l pmol/l pmol/l pmol/l Sowers, et al. Fertil Steril

17 Validated AMH age nomogram for DSL N>25,000 Nelson, et al. Fertil Steril. 2010, submitted 2011.

18 Does AMH relate to ovarian response? Large prospective cohort of 340 women undergoing their first IVF cycle with a standard agonist approach: Prostap and 225IU AMH strongly correlates with oocyte yield AMH distinguishes treatment categories FSH does not Nelson, et al. Hum Reprod

19 AMH correlates with oocyte yield and is better than other predictors Author n R with oocytes AMH better than Ov. Vol d3 FSH d3 E 2 d3 inhb age Seifer (2002) Van Rooij (2002) Fanchin (2003) Muttukrishna (2004) Hazout (2004) Muttukrishna (2005) Elder Geva (2005) Ficicioglu (2006) La Marca (2007) Kwee (2007) Elgindy (2007) Nelson (2007) Wunder (2008) X Gnoth (2008) 132 Nardo (2008) La Marca, et al. Hum Reprod. Update 2010.

20 AMH for poor response: CUT-OFF values Author n Study design CUT-OFF value (ng/ml) Sens (%) Spec (%) Van Rooij (2002) 119 Prosp Muttukrishna (2004) 69 Prosp Muttukrishna (2005) 108 Retro Tremellen (2005) 75 Prosp Panarrubia (2005) 80 Prosp Ebner (2006) 141 Prosp Ficicioglu (2006) 50 Prosp La Marca (2007) 48 Prosp Smeenk (2007) 80 Prosp McIlveen (2007) 84 Prosp Kwee (2007) 110 Prosp Nelson (2007) 340 Prosp (correctly classified) Gnoth (2008) 132 Prosp AMH <1.0pmol/L only a few pregnancies to term La Marca, et al. Hum Reprod. Update 2010.

21 AMH - prediction of over-response Author n Study design CUT-OFF value (ng/ml) Sens (%) Spec (%) Prediction of hyper-response Kwee (2007) 110 Prosp Nelson (2007) 340 Prosp Prediction of OHSS Lee (2008) 262 Prosp Strengths: High number of patients Optimal classification of OHSS Only moderate to severe OHSS considered Limitations: Limited to Chinese population Not clear definition of PCOS women included TH Lee, et al. Hum Reprod

22 So can we use AMH to inform IVF? AMH: Stable molecule Relatively stable across cycle Stable between cycles One assay on the market Age related nomogram quadratic Strongly related to oocyte yield Can predict poor response Can predict excessive response Independent of age How can we utilise this information?

23 Prospective Evaluation of AMH based strategies Centre 1 (370) Control FSH Dose AMH Centre 2 (168) Control FSH Dose Agonist 150 High Response Risk of OHSS Antagonist Agonist 225 Normal Response Agonist Agonist 300 Reduced Response Antagonist 300 Antagonist Negligible Response Modified Natural Cycle Nelson, et al. Hum Reprod 2009.

24 Egg Yields % Cycles Lower oocyte yields in high responders Centre1 Centre 2 Excessive response P < P < Antagonist Agonist Antagonist Antagonist Reduced AMH Pmol/L Normal 5 15 Pmol/L High AMH >15 Pmol/L HighAMH >15 Pmol/L Reduced OHSS Nelson, et al. Hum Reprod

25 Individualisation significantly improves clinical pregnancy rates Centre1 Centre 2 P < Antagonist % Cycles 40 Agonist Agonist 20 Agonist Antagonist 0 Reduced AMH Pmol/L Normal AMH 5 15 Pmol/L High AMH >15 Pmol/L Adjusted for age and AMH antagonist protocol had substantially higher clinical pregnancy rates per cycle started [OR 4.40 (95% CI ), p<0.001] Nelson, et al. Hum Reprod

26 AMH dictated strategic approach AMH High Responders (150IU daily) Normal Responders Reduced Responders Negligible response Control FSH Dose Agonist Strategy Antagonist nwt Strategy / Obese Lower FSH dose normalised egg yields has Antagonist: negligible FSH + LH Negligible excess 150 / 225 responses impact on excess Low cryopreservation responses. High / maintained fresh CPR High cryopreservation Similar Agonist: outcomes HMG in or both rfsh centres: using GnRH 225 / 300 Agonist Negligible failure of OPU & over-stimulation rates High Dose FSH: Antagonist Strategy Long Minimal stimulation Short stimulation 225 / 300 High treatment cancellation Moderate cancellation No benefit burden from e.g. flare Reduced treatment higher FSH dose burden.

27 Composite measures incorporating AMH AMH and age are independent predictors of oocyte yield IMPORT consortium submitted.

28 Composite measures incorporating AMH AMH and age are independent predictors of oocyte yield AUROC 95% CI Age , 0.64 AMH , 0.83 Age & FSH , 0.77 Age & AFC , 0.80 Age & AMH , 0.84 Age & AMH & AFC , 0.86 Age & AMH & AFC &FSH , 0.86 IMPORT consortium submitted.

29 Composite measures incorporating AMH AMH and age are independent predictors of oocyte yield Maximal value is from AMH Never mind their age just measure AMH AUROC 95% CI Age , 0.64 AMH , 0.83 Age & FSH , 0.77 Age & AFC , 0.80 Age & AMH , 0.84 Age & AMH & AFC , 0.86 Age & AMH & AFC &FSH , 0.86 IMPORT consortium submitted.

30 So utilising biomarkers? Individualise expectations of oocyte yield Individualise treatment strategies Improve safety of IVF Prospectively evaluate novel therapies A role independent of the classical biomarker date of birth?

31 What are our chances of having a baby?

32 Can biomarkers predict spontaneous pregnancy? Increasing FSH reduced fecundity 40% decrease if FSH 15 U/litre Independent of age and cycle length Van der Steeg et al 2007 JCEM.

33 Can AMH predict spontaneous pregnancy? Low AMH associated with reduced chance of spontaneous pregnancy Steiner et al Obstetrics & Gynecol 2011

34 Can you predict fertility post chemo? Use menses as surrogate for fertility Pre treatment AMH higher in those with menses 5 years post chemo Amenorrhea Anderson et al 2011 JCEM.

35 Can you predict fertility post chemo? Use menses as surrogate for fertility Pre treatment AMH higher in those with menses 5 years post chemo AMH better predictor of amenorrhoea than age Anderson et al 2011 JCEM.

36 Can you predict fertility post chemo? Use menses as surrogate for fertility Pre treatment AMH higher in those with menses 5 years post chemo Anna AMH better predictor of amenorrhoea than age Sarah AMH may predict those who will benefit from cryopreservation Anderson et al 2011 JCEM.

37 Can you predict fertility post chemo? Use menses as surrogate for fertility Pre treatment AMH higher in those with menses 5 years post chemo Anna AMH better predictor of amenorrhoea than age Sarah AMH may predict those who will benefit from cryopreservation Anderson et al 2011 JCEM.

38 Can biomarkers predict IVF live birth? No everything including age awful Limitation of ROC analysis IMPORT consortium submitted.

39 Can biomarkers predict IVF live birth? Yes if you think of predict in conventional terms of low medium, or high risk Age (years) AMH (ng/ml) < > (0.01 to 0.16) 0.18 (0.12 to 0.26) 0.29 (0.17 to 0.44) (0.02 to 0.24) 0.27 (0.21 to 0.35) 0.40 (0.28 to 0.54) < (0.04 to 0.36) 0.38 (0.26 to 0.51) 0.52 (0.38 to 0.67) *Values in parenthesis are 95% confidence intervals La Marca and Nelson 2010 RBMO.

40 Will biomarkers add to established risk estimates? 144,000 fresh IVF cycles Baseline characteristics Freely available Nelson and Lawlor Plos Medicine IVFpredict.com

41 Live birth rate Accurate calibration is the key Observed Predicted Deciles of risk Nelson and Lawlor Plos Medicine IVFpredict.com

42 Live birth rate Accurate calibration is the key Observed Predicted Deciles of risk Nelson and Lawlor Plos Medicine IVFpredict.com

43 Summary Just do IVF is no longer an option Accurate prediction of live birth is feasible AMH is easy and relatively stable AFC accuracy is essential AFC and AMH relate strongly to oocyte yield Biomarkers can predict spontaneous live birth Biomarkers can direct fertility preservation Biomarkers can individualise expectations and treatment Biomarkers can improve outcomes and safety of IVF

44 Summary And your biomarker - AMH

45 GCRM Labs your AMH provider GCRMlabs.com

46 GCRM Labs your AMH provider GCRMlabs.com

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology Minimising IVF related mortality and morbidity Scott Nelson Muirhead Professor in Obstetrics & Gynaecology We rarely say no - so what I will cover today VTE as an example of a modifiable IVF complication

More information

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology Thrombosis during assisted reproduction Scott Nelson Muirhead Chair in Obstetrics & Gynaecology ART can be as safe as natural pregnancy!! What used to be the risk of thrombosis in ART!! We can use AMH

More information

Individualized treatment based on ovarian reserve markers

Individualized treatment based on ovarian reserve markers Individualized treatment based on ovarian reserve markers Prof Dr. Nikolaos P. Polyzos M.D. PhD Professor and Medical Co- Director, Vrije Universiteit Brussel, UZ Brussel, Belgium Professor of Reproduc?ve

More information

AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF. Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD

AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF. Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD INTRODUCTION Ovarian stimulation is an important process in IVF treatment, aiming at obtain a number

More information

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity

More information

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate

More information

The emergence of Personalized Medicine protocols for IVF.

The emergence of Personalized Medicine protocols for IVF. Individualising IVF: Introduction to the POSEIDON Concept Introduction The emergence of Personalized Medicine protocols for IVF. Differences between patients: age, ovarian reserve, BMI or presence of ovarian

More information

Poor & Hyper responders: what is the best approach?

Poor & Hyper responders: what is the best approach? Poor & Hyper responders: what is the best approach? A. La Marca ObGyn Dept University of Modena and Reggio Emilia Italy Center for Reproductive Medicine University Hospital of Modena Italy Criteria used

More information

Personalizing ovarian stimulation for IVF

Personalizing ovarian stimulation for IVF Personalizing ovarian stimulation for IVF Biljana Popovic-Todorovic MD,PhD Centre for Reproductive Medicine UZ Brussel QuickTime and are needed to see this picture. Controlled ovarian stimulation for IVF/ICSI

More information

JMSCR Vol 06 Issue 09 Page September 2018

JMSCR Vol 06 Issue 09 Page September 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i9.53 Role of Anti-Mullerian Hormone

More information

A Tale of Three Hormones: hcg, Progesterone and AMH

A Tale of Three Hormones: hcg, Progesterone and AMH A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,

More information

NGUYEN QUOC ANH. M.D., M.Sc. Tu Du Hospital Vietnam

NGUYEN QUOC ANH. M.D., M.Sc. Tu Du Hospital Vietnam NGUYEN QUOC ANH M.D., M.Sc. Tu Du Hospital Vietnam FULLY AUTOMATED AMH TESTING OF OVARIAN RESPONSE IN IVF NGUYỄN QUỐC ANH MD. Infertility dep. Tudu hospital Index What is AMH? Standard AMH testing Fully

More information

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G

More information

Prognosticating ovarian reserve by the new ovarian response prediction index

Prognosticating ovarian reserve by the new ovarian response prediction index International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917

More information

Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve

Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve Original Article Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve Sonal Panchal, Chaitanya Nagori Dr. Nagori s Institute for Infertility and IVF, Ellisbridge,

More information

Ovarian Ageing: mechanisms and clinical consequences Reproductive Ageing: a basic and clinical update SSIF, Taormina, April 29 and 30, 2011

Ovarian Ageing: mechanisms and clinical consequences Reproductive Ageing: a basic and clinical update SSIF, Taormina, April 29 and 30, 2011 Ovarian Ageing: mechanisms and clinical consequences Reproductive Ageing: a basic and clinical update SSIF, Taormina, April 29 and 30, 2011 Frank J Broekmans Professor Reproductive Medicine and Surgery

More information

Principles of Ovarian Stimulation

Principles of Ovarian Stimulation Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle

More information

Questions. Ultrasound markers of ovarian reserve Modena April 18-19, Your choice is.. Impact study: stop OR tests or Soft catheters??

Questions. Ultrasound markers of ovarian reserve Modena April 18-19, Your choice is.. Impact study: stop OR tests or Soft catheters?? Ultrasound markers of ovarian reserve Modena April 18-19, 2008 Frank J Broekmans Reproductive Medicine UMC Utrecht Impact study: stop OR tests or Soft catheters?? Stop OR screening, cost reduction 21 euro

More information

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte

More information

Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation

Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Aim: To determine whether a follicle-stimulating hormone (FSH)/luteinizing

More information

Individualized Controlled Ovarian Stimulation: Biomarker-Guided Treatment Personalization

Individualized Controlled Ovarian Stimulation: Biomarker-Guided Treatment Personalization WHITE PAPER Individualized Controlled Ovarian Stimulation: Biomarker-Guided Treatment Personalization Author: Antonio La Marca, MD, PhD, Clinica Eugin and University of Modena and Reggio Emilia, Modena,

More information

Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors

Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors Reproductive BioMedicine Online (2010) 20, 42 47 www.sciencedirect.com www.rbmonline.com ARTICLE Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors

More information

ENDOCRINE CHARACTERISTICS OF ART CYCLES

ENDOCRINE CHARACTERISTICS OF ART CYCLES ENDOCRINE CHARACTERISTICS OF ART CYCLES DOÇ. DR. SEBİHA ÖZDEMİR ÖZKAN KOCAELI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, IVF UNIT 30.04.2014, ANTALYA INTRODUCTION The endocrine

More information

Anti-Müllerian hormone as a predictor of pregnancy following IVF

Anti-Müllerian hormone as a predictor of pregnancy following IVF Reproductive BioMedicine Online (2013) 26, 247 252 www.sciencedirect.com www.rbmonline.com ARTICLE Anti-Müllerian hormone as a predictor of pregnancy following IVF Priya Bhide a, *, Anil Gudi a, Amit Shah

More information

Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Milder is better? Advantages and disadvantages of mild ovarian stimulation for human in vitro fertilization Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background

More information

STIMULATION AND OVULATION TRIGGERING

STIMULATION AND OVULATION TRIGGERING STIMULATION AND OVULATION TRIGGERING Professor IOANNIS E. MESSINIS MD, PhD (Aberdeen, UK), FRCOG (UK) Department of Obs/Gynae University of Thessaly Larissa, GREECE DISCLOSURE Nothing to disclose Learning

More information

Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest

Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain Declared no potential conflict of interest Is there a role for LH in elderly patients? Dr. Ernesto Bosch Instituto Valenciano de Infertilidad.

More information

The value of anti-müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophindose adjustments

The value of anti-müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophindose adjustments Human Reproduction, Vol.27, No.6 pp. 1829 1839, 2012 Advanced Access publication on April 3, 2012 doi:10.1093/humrep/des101 ORIGINAL ARTICLE Reproductive endocrinology The value of anti-müllerian hormone

More information

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective

More information

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health. Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive

More information

Best practices of ASRM and ESHRE

Best practices of ASRM and ESHRE Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction

More information

LH activity administration during the

LH activity administration during the LH activity administration during the luteal-follicular transition Richard Fleming On behalf of the Luveris Pre-treatment group University of Glasgow Scotland Androgens have a Paracrine action in the Early

More information

Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR)

Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR) Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR) Geeta Nargund Head of Reproductive Medicine St George s Hospital London ISMAAR Terminology Human Reprod Nargund et al

More information

External validation of anti-müllerian hormone based prediction of live birth in assisted conception

External validation of anti-müllerian hormone based prediction of live birth in assisted conception Khader et al. Journal of Ovarian Research 2013, 6:3 RESEARCH Open Access External validation of anti-müllerian hormone based prediction of live birth in assisted conception Amani Khader 1, Suzanne M Lloyd

More information

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Is it the seed or the soil? Arthur Leader, MD, FRCSC The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events

More information

2015 Elsevier. Link to publisher version: doi: /j.fertnstert Deposited on: 23 June 2016

2015 Elsevier. Link to publisher version: doi: /j.fertnstert Deposited on: 23 June 2016 Nelson, S. M., Pastuszek, E., Kloss, G., Malinowska, I., Liss, J., Lukaszuk, A., Plociennik, L., and Lukaszuk, K. (2015) Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian

More information

The ovarian response resulting

The ovarian response resulting Comparison of antim ullerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two

More information

Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients

Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients ORIGINAL REPORT Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients Ashraf Aleyasin, Marzie Aghahoseini, Sara Mokhtar, and Parvin Fallahi

More information

A new approach to IVF? Soft or mild IVF. Soft or mild IVF

A new approach to IVF? Soft or mild IVF. Soft or mild IVF A new approach to IVF? William Ledger University of Sheffield Centre for Reproductive Medicine and Fertility (w.ledger@sheffield.ac.uk) Soft or mild IVF Less patient discomfort Less complex, shorter stimulation

More information

Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation

Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation ORIGINAL ARTICLE http://dx.doi.org/.63/cerm.216.43.2.112 pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 216;43(2):112-118 Nomogram to predict the number of oocytes retrieved in controlled ovarian

More information

Correlation between three assay systems for anti-müllerian hormone (AMH) determination. Li, RHW; Ng, EHY; Wong, BPC; Anderson, RA; Ho, PC; Yeung, WSB

Correlation between three assay systems for anti-müllerian hormone (AMH) determination. Li, RHW; Ng, EHY; Wong, BPC; Anderson, RA; Ho, PC; Yeung, WSB Title Correlation between three assay systems for anti-müllerian hormone (AMH) determination Author(s) Li, RHW; Ng, EHY; Wong, BPC; Anderson, RA; Ho, PC; Yeung, WSB Citation Journal of Assisted Reproduction

More information

Oocyte Freezing and Ovarian Tissue Cryopreservation:

Oocyte Freezing and Ovarian Tissue Cryopreservation: Oocyte Freezing and Ovarian Tissue Cryopreservation: Comparing Results of These Two Methods in One Program Dr. César Díaz García cesar.diaz@ivi.uk IVI London 83, Wimpole St. London, UK London Conflict

More information

Infertility Clinical Guideline

Infertility Clinical Guideline Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist

More information

L6: DuoStim: the alternative of oocytes/embryos accumulation programs Carlo Alviggi

L6: DuoStim: the alternative of oocytes/embryos accumulation programs Carlo Alviggi L6: DuoStim: the alternative of oocytes/embryos accumulation programs Carlo Alviggi Italy What is the aim of IVF? What is the measure of success in IVF? Cumulative live birth rate per started cycle Live

More information

Advanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy

Advanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy Advanced age, poor responders and the role of LH supplementation C. Alviggi University Federico II, Naples, Italy LH serum level (IU/L) 20.0 15.0 10.0 5.0 0.0 LH levels during spontaneous and stimulated

More information

10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States.

10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States. The purview of pediatrics includes the growth, development, and health of the child and therefore begins in the period before birth when conception is apparent. It continues through childhood and adolescence

More information

Anti-Mullerian hormone (AMH) as predictor of ovarian reserve

Anti-Mullerian hormone (AMH) as predictor of ovarian reserve International Journal of Reproduction, Contraception, Obstetrics and Gynecology Shembekar CA et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):4006-4010 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174053

More information

Number of oocytes and live births in IVF

Number of oocytes and live births in IVF Number of oocytes and live births in IVF Dr Sesh K Sunkara MD, MRCOG Royal Marsden Hospital, London Kings Healthcare Partners (Guy s & St Thomas NHS Foundation Trust), London, UK Background IVF results

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

Ovarian hyperstimulation syndrome (OHSS)

Ovarian hyperstimulation syndrome (OHSS) Ovarian hyperstimulation syndrome (OHSS) OHSS OHSS: exaggerated response to gonadotropins and hcg Characterized by: ovarian enlargement increased vascular permeability fluid accumulation in abdomen Associated

More information

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of Endometrioma and deep infiltrating endometriosis Professor C. Chapron and the Group

More information

PUBLISHED SCIENTIFIC EVIDENCE ON THE USE OF ANTI-MÜLLERIAN HORMONE. Anti-Müllerian Hormone (AMH)

PUBLISHED SCIENTIFIC EVIDENCE ON THE USE OF ANTI-MÜLLERIAN HORMONE. Anti-Müllerian Hormone (AMH) PUBLISHED SCIENTIFIC EVIDENCE ON THE USE OF ANTI-MÜLLERIAN HORMONE Anti-Müllerian Hormone (AMH) Table of Contents» Fertility Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara

More information

Research Article. Jayakrishnan Krishnakumar 1, Akansha Agarwal 1, Divya Nambiar 1, Shankar Radhakrishnan 2 *

Research Article. Jayakrishnan Krishnakumar 1, Akansha Agarwal 1, Divya Nambiar 1, Shankar Radhakrishnan 2 * International Journal of Reproduction, Contraception, Obstetrics and Gynecology Krishnakumar J et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2762-2767 www.ijrcog.org pissn 2320-1770 eissn

More information

Medicine, University of Glasgow, Glasgow, United Kingdom; and c The Fertility Clinic, Odense University Hospital, Odense, Denmark

Medicine, University of Glasgow, Glasgow, United Kingdom; and c The Fertility Clinic, Odense University Hospital, Odense, Denmark Does the time interval between antim ullerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization intracytoplasmic sperm injection cycles

More information

Utility of Estradiol as a Predictive Marker of Ovarian Hyper Stimulation Syndrome

Utility of Estradiol as a Predictive Marker of Ovarian Hyper Stimulation Syndrome Research Article imedpub Journals http://www.imedpub.com/ Annals of Clinical and Laboratory Research DOI: 10.21767/2386-5180.1000167 Utility of Estradiol as a Predictive Marker of Ovarian Hyper Stimulation

More information

Intérêt de l hcg et induction de l ovulation. Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium

Intérêt de l hcg et induction de l ovulation. Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium Intérêt de l hcg et induction de l ovulation Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium Conflict of interest The opinions expressed in this document are the opinions

More information

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life?

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? Vitaly A. Kushnir MD Center for Human Reproduction New York City Milestones

More information

Evaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis

Evaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pillai SM et al. Int J Reprod Contracept Obstet Gynecol. 2017 Aug;6(8):3306-3310 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20173190

More information

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management Dr Guy Gudex Director Repromed 17:00-17:30 Recent Advances in Fertility Management Recent Advances in Fertility Management Practice Nurses Programme NZMA GP CME June 2018 Dr Guy Gudex ART in NZ -2014 ACART

More information

The old IVF patient: An evidence based approach. Stratis Kolibianakis MD MSc PhD

The old IVF patient: An evidence based approach. Stratis Kolibianakis MD MSc PhD The old IVF patient: An evidence based approach Stratis Kolibianakis MD MSc PhD Unit for Human Reproduction 1 st Dept Ob/Gyn Aristotle University of Thessaloniki No conflict of interest How old is old?

More information

Serum anti-müllerian hormone predicts ovarian response and cycle outcome in IVF patients

Serum anti-müllerian hormone predicts ovarian response and cycle outcome in IVF patients J Assist Reprod Genet (2009) 26:383 389 DOI 10.1007/s10815-009-9332-8 ASSISTED REPRODUCTION Serum anti-müllerian hormone predicts ovarian response and cycle outcome in IVF patients Cheng-Hsuan Wu & Yu-Ching

More information

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility

More information

Predictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles

Predictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles Oehninger et al. Reproductive Biology and Endocrinology (2015) 13:117 DOI 10.1186/s12958-015-0113-1 RESEARCH Open Access Predictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist

More information

Sample size a Main finding b Main limitations

Sample size a Main finding b Main limitations 1 Table 1. Available studies on the relation between endometriosis and miscarriage (1995-2015). Study (citation) Country Study period Study design Sample size a Main finding b Main limitations Matoras

More information

ORIGINAL ARTICLE Reproductive endocrinology. A. Nyboe Andersen 1, H. Witjes 2, K. Gordon 3, and B. Mannaerts 4, * on behalf of the Xpect investigators

ORIGINAL ARTICLE Reproductive endocrinology. A. Nyboe Andersen 1, H. Witjes 2, K. Gordon 3, and B. Mannaerts 4, * on behalf of the Xpect investigators Human Reproduction, Vol.26, No.12 pp. 3413 3423, 2011 Advanced Access publication on September 27, 2011 doi:10.1093/humrep/der318 ORIGINAL ARTICLE Reproductive endocrinology Predictive factors of ovarian

More information

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn) 34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh

More information

(Predictive. value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In

(Predictive. value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In Ovarian Rese erve Lab Tests In (Predictive IVF value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In nstitute t Case Presentation 29 y/o,primary inf 1.5yr, Hx of irregular menses (

More information

Androgen supplementation in women with low functional ovarian reserve

Androgen supplementation in women with low functional ovarian reserve Androgen supplementation in women with low functional ovarian reserve Norbert Gleicher, MD Medical Director and Chief Scientist, Center For Human Reproduction, New York, NY President, Foundation For Reproductive

More information

Grynnerup et al. Reproductive Biology and Endocrinology (2019) 17:11

Grynnerup et al. Reproductive Biology and Endocrinology (2019) 17:11 Grynnerup et al. Reproductive Biology and Endocrinology (2019) 17:11 https://doi.org/10.1186/s12958-019-0452-4 RESEARCH Prediction of the lower serum anti- Müllerian hormone threshold for ovarian stimulation

More information

The meaning of anti-müllerian hormone levels in patients at a high risk of poor ovarian response

The meaning of anti-müllerian hormone levels in patients at a high risk of poor ovarian response REVIEW pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2016;43(3):139-145 The meaning of anti-müllerian hormone levels in patients at a high risk of poor ovarian response Hyun Jong Park 1, Geun Ho

More information

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

2017 United HealthCare Services, Inc.

2017 United HealthCare Services, Inc. UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017

More information

HCG mode of action versus GnRHa action for triggering of final oocyte maturation

HCG mode of action versus GnRHa action for triggering of final oocyte maturation HCG mode of action versus GnRHa action for triggering of final oocyte maturation Nick Macklon Professor of Obstetrics and Gynaecology, University of Southampton A hammer to crack a nut hcg? How hard does

More information

Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017.

Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017. Fertility Policy 10 July 2017 Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017. Introduction BHR CCGs are responsible

More information

Article Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?

Article Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? RBMOnline - Vol 16. No 5. 2008 664-670 Reproductive BioMedicine Online; www.rbmonline.com/article/3179 on web 11 March 2007 Article Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality

More information

Modified natural cycles: the Italian experience

Modified natural cycles: the Italian experience CLINICA VALLE GIULIA, Rome Modified natural cycles: the Italian experience Filippo Maria Ubaldi M.D. M.Sc. Poor ovarian Response ESHRE Campus symposium Bologna 19-20 March 2010 Introduction Ovarian superovulation

More information

Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?

Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG: an International Journal of Obstetrics and Gynaecology October 2005, Vol. 112, pp. 1384 1390 DOI: 10.1111/j.1471-0528.2005.00670.x Antral follicle count, anti-mullerian hormone and inhibin B: predictors

More information

Reproductive function in cancer survivors

Reproductive function in cancer survivors Reproductive function in cancer survivors Professor W Hamish Wallace hamish.wallace@nhs.net Symposium 20: Endocrine consequences of childhood cancer treatment Liffey Hall 2, 0905 19 May 2015 CONFLICT OF

More information

Clinical Study Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction

Clinical Study Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction Obstetrics and Gynecology International Volume 2013, Article ID 383278, 6 pages http://dx.doi.org/10.1155/2013/383278 Clinical Study Discrepancies between Antimullerian Hormone and Follicle Stimulating

More information

Serum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study

Serum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study International Journal of Reproduction, Contraception, Obstetrics and Gynecology Amin KV et al. Int J Reprod Contracept Obstet Gynecol. 2018 Aug;7(8):3194-3198 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183316

More information

International Journal of Pharma and Bio Sciences ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN ABSTRACT

International Journal of Pharma and Bio Sciences ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN ABSTRACT Research Article Biochemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN BUSHRA FIZA *, 1, 2, RATI MATHUR 2, MAHEEP

More information

Manish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group

Manish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group Manish Banker Nova IVI Fertility Pulse Women's Hospital Gujarat, India Declared receipt of grants; member of a company advisory board, board of director or similar group The Indian point of view Manish

More information

Does PCOS Compromise the oocyte and embryo quality or the endometrium?

Does PCOS Compromise the oocyte and embryo quality or the endometrium? Does PCOS Compromise the oocyte and embryo quality or the endometrium? Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Disclosures Consultant: Bayer, Ogeda (Euroscreen),

More information

S. DEB*, B. K. CAMPBELL, J. S. CLEWES, C. PINCOTT-ALLEN and N. J. RAINE-FENNING

S. DEB*, B. K. CAMPBELL, J. S. CLEWES, C. PINCOTT-ALLEN and N. J. RAINE-FENNING Ultrasound Obstet Gynecol 2013; 41: 21 222 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI:.02/uog.1122 Intracycle variation in number of antral follicles stratified by size and

More information

Treatment of Poor Responders

Treatment of Poor Responders Treatment of Poor Responders Pathophysiology of Poor Responders Deficiency in systemic IGF 1 levels (Bahceci, 2007) Lower intra ovarian T levels Reduced FSH receptor expression (Cai, 2007) Bahceci, 2007,

More information

La preservazione della fertilità in oncologia: il carcinoma mammario come paradigma. Olivia Pagani Centro di Senologia dellasvizzera Italiana

La preservazione della fertilità in oncologia: il carcinoma mammario come paradigma. Olivia Pagani Centro di Senologia dellasvizzera Italiana La preservazione della fertilità in oncologia: il carcinoma mammario come paradigma Olivia Pagani Centro di Senologia dellasvizzera Italiana Centro di Senologia della Svizzera Italiana Pregnancy rate after

More information

Raoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest

Raoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest Raoul Orvieto The Chaim Sheba Medical Center Tel Hashomer, Israel Declared no potential conflict of interest LH in antagonist cycles; is the story really written? Raoul Orvieto M.D. Israel Overview Role

More information

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1 Puberty and Fertility Jennifer Badik*, MD Pediatric Endocrinology and Jessica Spencer*, MD, MSc Reproductive Endocrinology and Infertility Part One PUBERTY! *no conflicts of interest to report Every girl

More information

FERTILITY PRESERVATION. Sanghoon Lee & Sinan Ozkavukcu & Elke Heytens & Fred Moy & Rose M. Alappat & Kutluk Oktay

FERTILITY PRESERVATION. Sanghoon Lee & Sinan Ozkavukcu & Elke Heytens & Fred Moy & Rose M. Alappat & Kutluk Oktay J Assist Reprod Genet (2011) 28:651 656 DOI 10.1007/s10815-011-9567-z FERTILITY PRESERVATION Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes

More information

Miro Šimun AlebiT, 1 Nataša StojanoviT, 2 and Marta CuviT-Butorac Introduction

Miro Šimun AlebiT, 1 Nataša StojanoviT, 2 and Marta CuviT-Butorac Introduction International Endocrinology Volume 2013, Article ID 637919, 7 pages http://dx.doi.org/10.1155/2013/637919 Research Article The IVF Outcome Counseling Based on the Model Combining DHEAS and Age in Patients

More information

Ontogeny of the new hypo-androgenic PCOS phenotype

Ontogeny of the new hypo-androgenic PCOS phenotype Ontogeny of the new hypo-androgenic PCOS phenotype Norbert Gleicher, MD Medical Director and Chief Scientist, Center For Human Reproduction, New York, NY President, Foundation For Reproductive Medicine,

More information

(BMI)=18.0~24.9 kg/m 2 ;

(BMI)=18.0~24.9 kg/m 2 ; 33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV

More information

CONTROLLED OVARIAN HYPERSTIMULATION AND OOCYTE RETRIEVAL : CLINICAL INPUTS. DR Priyanka Sinha MD OB-GYN MUMBAI, INDIA

CONTROLLED OVARIAN HYPERSTIMULATION AND OOCYTE RETRIEVAL : CLINICAL INPUTS. DR Priyanka Sinha MD OB-GYN MUMBAI, INDIA CONTROLLED OVARIAN HYPERSTIMULATION AND OOCYTE RETRIEVAL : CLINICAL INPUTS DR Priyanka Sinha MD OB-GYN MUMBAI, INDIA LEARNING OBJECTIVE Introduction Ovarian stimulation protocols Comparison of different

More information

Using AMH for determining a stratified gonadotropin dosing regimen for IVF/ICSI and optimizing outcomes

Using AMH for determining a stratified gonadotropin dosing regimen for IVF/ICSI and optimizing outcomes IMPORTANT COPYRIGHT NOTICE: This electronic article is provided to you by courtesy of Ferring Pharmaceuticals. The document is provided for personal usage only. Further reproduction and/or distribution

More information

Approved January Waltham Forest CCG Fertility policy

Approved January Waltham Forest CCG Fertility policy Approved January 2015 Waltham Forest CCG Fertility policy Contents 1 Introduction 1 2 Individual Funding Requests 1 2.1 Eligibility criteria 1 2.2 Number of cycles funded 2 2.3 Treatment Pathway 3 Page

More information

High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol

High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol Human Reproduction, Vol.28, No.2 pp. 442 452, 2013 Advanced Access publication on November 7, 2012 doi:10.1093/humrep/des389 ORIGINAL ARTICLE Reproductive endocrinology High ovarian response does not jeopardize

More information

Original Research Article

Original Research Article RATIONALE OF INCORPORATING SERUM ANTI-MULLERIAN HORMONE ESTIMATIONS IN DIAGNOSING PREMATURE OVARIAN FAILURE Pranay Phukan 1, Surajeet Boruah 2 1Associate Professor, Department of Obstetrics and Gynaecology,

More information